Axonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations  by Alami, Nael H. et al.
Neuron
ReportAxonal Transport of TDP-43 mRNA Granules
Is Impaired by ALS-Causing Mutations
Nael H. Alami,1,8 Rebecca B. Smith,1,8 Monica A. Carrasco,2 Luis A. Williams,3 Christina S. Winborn,4 Steve S.W. Han,3,5
Evangelos Kiskinis,3 Brett Winborn,1 Brian D. Freibaum,1 Anderson Kanagaraj,1 Alison J. Clare,1 Nisha M. Badders,1
Bilada Bilican,6 Edward Chaum,4 Siddharthan Chandran,6 Christopher E. Shaw,7 Kevin C. Eggan,3 Tom Maniatis,2
and J. Paul Taylor1,*
1Department of Developmental Neurobiology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
2Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, NY 10032, USA
3Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA
4Department of Ophthalmology, University of Tennessee Health Sciences Center, Memphis, TN 38163, USA
5Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA
6Euan MacDonald Centre for Motor Neurone Disease Research, Medical Research Council Centre for Regenerative Medicine,
Centre for Neuroregeneration, University of Edinburgh, Edinburgh EH16 4SB, UK
7Departments of Clinical Neuroscience and Neurodegeneration and Brain Injury, King’s College London and King’s Health Partners,
MRC Centre for Neurodegeneration Research, London SE5 8AF, UK
8These authors contributed equally to this work
*Correspondence: jpaul.taylor@stjude.org
http://dx.doi.org/10.1016/j.neuron.2013.12.018SUMMARY
The RNA-binding protein TDP-43 regulates RNA
metabolism at multiple levels, including transcrip-
tion, RNA splicing, and mRNA stability. TDP-43 is
a major component of the cytoplasmic inclusions
characteristic of amyotrophic lateral sclerosis and
some types of frontotemporal lobar degeneration.
The importance of TDP-43 in disease is underscored
by the fact that dominant missense mutations are
sufficient to cause disease, although the role of
TDP-43 in pathogenesis is unknown. Here we show
that TDP-43 forms cytoplasmic mRNP granules
that undergo bidirectional, microtubule-dependent
transport in neurons in vitro and in vivo and facilitate
delivery of target mRNA to distal neuronal compart-
ments. TDP-43 mutations impair this mRNA trans-
port function in vivo and in vitro, including in stem
cell-derived motor neurons from ALS patients
bearing any one of three different TDP-43 ALS-
causing mutations. Thus, TDP-43 mutations that
cause ALS lead to partial loss of a novel cytoplasmic
function of TDP-43.
INTRODUCTION
Transactive response DNA-binding protein 43 (TDP-43) is
a highly conserved, ubiquitously expressed heterogeneous
ribonucleoprotein (hnRNP) that is primarily nuclear but shuttles
between the cytoplasm and nucleus. TDP-43 was initially
identified as a transcription repressor (Ou et al., 1995) and
splicing regulator (Buratti et al., 2001) and later recognized536 Neuron 81, 536–543, February 5, 2014 ª2014 Elsevier Inc.as the major component of pathological cytoplasmic inclu-
sions characteristic of frontotemporal lobar degeneration
(FTLD), amyotrophic lateral sclerosis (ALS), and inclusion
body myopathy (Neumann et al., 2006). Dominant mutations
in TDP-43 are sufficient to cause familial forms of those dis-
eases, underscoring its role in pathogenesis (Al-Chalabi
et al., 2012). The identification of mutations in related RNA
processing proteins has focused interest on perturbed RNA
metabolism as a potential common defect underlying neuro-
degenerative diseases (Kim et al., 2013; Kwiatkowski et al.,
2009; Ramaswami et al., 2013), yet the role(s) of TDP-43 in
RNA metabolism is far from complete. How disease-causing
mutations disrupt TDP-43 function(s), the relative contribution
of toxic gain versus loss of function to disease, and the
cellular compartment(s) in which this perturbation occurs,
remains to be determined.
TDP-43 binds to thousands of mRNAs, many of which
are important in brain development and synaptic function,
but regulates alternative splicing of a small subset of these
(Polymenidou et al., 2011; Tollervey et al., 2011; Xiao et al.,
2011). Isolation of TDP-43 from a cytoplasmic fraction of
human brain revealed binding to the 30 UTR of numerous
target mRNAs, suggesting a role in mRNA stability and/
or transport (Tollervey et al., 2011). TDP-43 copurifies
with proteins involved in RNA transport (Freibaum et al.,
2010), is trafficked in neurons (Fallini et al., 2012; Wang
et al., 2008), and is detected in distal compartments such as
the presynaptic membrane of axon terminals in the neuro-
muscular junction in mice (Narayanan et al., 2013). As such,
it has been suggested that TDP-43 plays a role in the
transport of certain target mRNAs into distal neuronal pro-
cesses, but direct evidence is lacking (Lagier-Tourenne
et al., 2010). The extent to which this hypothetical function
might be compromised by disease mutations has not been
explored.
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Kinetics of TDP-43 Granules in Fly Motor
Neurons
(A–C) Venus-TDP-43WT (A), Venus-TDP-43M337V
(B), and Venus-TDP-43A315T (C) granules displayed
bidirectional movement along motor neuron axons
of third-instar larvae. Transport of mutant TDP-43
granules showed normal instantaneous velocities
but an increased frequency of reversals and
diminished net anterograde movement. Scale bar,
10 mm. (D–F) Kymographs tracing wild-type (D),
M337V (E), and A315T (F). Quantification of
displacement (G) and instantaneous velocities (H)
of wild-type and mutant granules in fly motor
axons. Anterograde and retrograde movements
are represented as positive or negative values on
the y axis, respectively. (I) Analysis of movement
directionality shows a reduced ratio of anterograde
to retrograde movement for mutant TDP-43 gran-
ules relative to TDP-43WT. (J) Quantification of
fluorescence intensities in fly motor neurons. The
ratio of average fluorescence intensity per pixel at
the synaptic terminal divided by the fluorescence
at the cell body shows that Venus-TDP-43WT sig-
nals higher than that of mutant TDP-43. Error bars
are shown as mean ± SEM.
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Axonal Trafficking of TDP-43 Granules in Drosophila
Motor Neurons Is Impaired by ALS Mutations
TDP-43 is highly conserved throughout the animal kingdom,
and knockout of the gene encoding TDP-43 is lethal in mouse
(Sephton et al., 2010). We used several model systems,
including Drosophila, mouse, and human stem cell-derived
motor neurons to systematically study TDP-43 function and
the consequence of disease mutations. Drosophila that lack
TBPH, the TDP-43 ortholog, typically die as pupae and es-
capers exhibit motor neuron synaptic dysfunction, progressive
loss of motor neurons, and reduced lifespan (Diaper et al.,
2013; Feiguin et al., 2009; Vanden Broeck et al., 2013). This
loss-of-function phenotype can be rescued by stably intro-
ducing wild-type human TDP-43 (TDP-43WT), illustrating con-
servation of TDP-43 function and validating Drosophila as a
relevant model system (Figure S1A available online). By
contrast, introduction of TDP-43 harboring ALS-causing muta-
tions (TDP-43M337V) at equivalent expression levels fails to
rescue the motor neuron defect (Figure S1A), suggesting that
at least one consequence of disease-causing mutation is par-
tial loss of function. To study TDP-43 in Drosophila in more
detail, we used PhiC31 integrase-mediated transgenesis to
generate animals expressing equal levels of fluorescently
tagged TDP-43WT, or either of the two ALS-causing mutants
TDP-43M337V or TDP-43A315T, and monitored protein localiza-
tion in motor neurons of animals with matched total expression
levels (Figures S1G and S1H). The distribution of TDP-43WT
was primarily nuclear as expected (Figures S1B, S1C, and
S1G), but we also observed numerous cytoplasmic granules
along the length of axons and extending into the neuromus-
cular junction (NMJ), where TDP-43 fluorescence was diffuse
(Figure S1G). By contrast, TDP-43M337V and TDP-43A315T accu-mulated in the cell soma and proximal axons (Figures S1B–
S1D) but was absent or reduced at distal axons and the
NMJ (Figures S1E and S1F). Live imaging of Drosophila motor
neurons revealed that both wild-type (Movie S1) and mutant
TDP-43 granules were transported bidirectionally for long dis-
tances with brief pauses (Figure 1A). We also observed that
mutant TDP-43 granules were not transported efficiently along
neuronal axons and displayed a less continuous movement
that is evident when plotted using kymographs (Figures 1A–
1F). The marked difference in subcellular distribution and trans-
port behavior of wild-type and mutant TDP-43 prompted us to
analyze the kinetics of TDP-43 transport in motor neurons. We
observed a significant reduction in net anterograde displace-
ment of TDP-43M337V and TDP-43A315T granules relative to
TDP-43WT granules (p = 0.027 and 0.018, respectively; Fig-
ure 1G; Table S1). Interestingly, we also observed that a
greater fraction of TDP-43M337V and TDP-43A315T granules
moved in the retrograde direction relative to TDP-43WT gran-
ules (Figure 1I). These data suggest impaired anterograde
movement of TDP-43M337V and TDP-43A315T granules along
motor neuron axons in vivo, leading to mutant TDP-43 accu-
mulation in the cytoplasm and proximal axons and deficiency
at the NMJ.
Axonal Trafficking of TDP-43Granules inMouseCortical
Neurons Is Selectively Impaired by ALS Mutations
The presence of TDP-43 in cytoplasmic granules in vivo that
are dynamic and transported along axons in Drosophila promp-
ted us to study the biology of these motile granules in primary
mouse cortical neurons. Under normal conditions, endogenous
TDP-43 was predominantly nuclear, as described previously
(Barmada et al., 2010), though cytoplasmic puncta in neurites
were also observed in most cells (Figure S2A). Exoge-
nous expression of mCherry-TDP-43WT showed the sameNeuron 81, 536–543, February 5, 2014 ª2014 Elsevier Inc. 537
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Figure 2. TDP-43 Transport in Primary
Cortical Neurons
(A) A wild-type TDP-43 granule (arrowhead) moves
along the axon of mouse cortical neuron in the
anterograde direction. Scale bar, 10 mm. (B) Three
representative tracings of TDP-43 granules mov-
ing along the axons of cortical neurons illustrating
anterograde displacement, retrograde displace-
ment, and reversal of directionality. The x axis
represents time and the y axis total distance along
the axon. (C) The number of moving TDP-43
granules in wild-type and mutant-transfected cells
were normalized to movements per hour and
plotted. Latrunculin treatment had no effect on
TDP-43 transport, while nocodazole-treated cells
contained dramatically fewer motile TDP-43
granules, demonstrating microtubule-dependent
movement. (D) The fraction of motile mutant TDP-
43 granules was significantly reduced compared
to TDP-43WT granules. (E)Mutant TDP-43 granules
reversed direction significantly more frequently
than TDP-43WT granules. (F) Kinetics of wild-type
and mutant TDP-43 transport show a significant
decrease in net displacement of TDP-43M337V (p <
0.001) and TDP-43A315T (p = 0.030 for anterograde
and 0.045 for retrograde) as compared to TDP-
43WT, and no significant change in instantaneous
velocities. (G) Kinetics of mitochondrial transport
show that there is no significant difference in
mitochondrial transport in cells transfected with
wild-type or mutant TDP-43. (H) The direction of
transport of TDP-43 granules was altered in cells
transfected with mutant TDP-43. A significantly
higher percentage of TDP-43M337V and TDP-
43A315T granules moved in the retrograde direction
as compared to TDP-43WT granules (p = 0.037 and
0.042, respectively). (I) The direction of mitochon-
drial transport was not altered in cells transfected
with wild-type or mutant TDP-43. All error bars are
shown as mean ± SEM.
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ALS Mutations Impair TDP-43 Granule Traffickingdistribution and enabled live imaging of TDP-43 (Figures S2B
and S2C). Time-lapse imaging of mCherry-tagged TDP-43
granules in the axons of cortical neurons maintained in culture
for 5 to 7 days revealed rapid, bidirectional, intermittent move-
ment (Figures 2A and 2B), consistent with the kinetics of TDP-
43 granule transport observed in Drosophila motor neurons.
The instantaneous velocities of TDP-43 granules in vivo and
in vitro (Table S1) were consistent with microtubule-dependent
fast axonal transport. TDP-43 granule movement was unaf-
fected by treatment with latrunculin, which disrupts actin fila-
ments, but abolished by treatment with nocodazole, which
disrupts microtubules (Figure 2C). This microtubule-dependent
transport of TDP-43 granules is consistent with long-range
axonal transport of protein complexes in neurons (Brown,
2013). To determine whether the ALS-causing mutations in
TDP-43 influence granule trafficking, we compared trafficking
parameters in neurons transfected with mCherry-TDP-43WT,
mCherry-TDP-43M337, or mCherry-TDP-43A315T. Although the
granule transport instantaneous velocities were indistinguish-
able, mCherry-TDP-43M337 and mCherry-TDP-43A315T granules
were more frequently immotile (p = 0.036 and 0.0027, respec-
tively) and reversed direction significantly more frequently (p =538 Neuron 81, 536–543, February 5, 2014 ª2014 Elsevier Inc.0.0017 and 0.0032, respectively; Figures 2D and 2E). These
altered trafficking parameters of mutant TDP-43 granules were
reflected in significant reductions in net displacement of TDP-
43M337V and TDP-43A315T (TDP-43M337V: p < 0.001 in both direc-
tions; TDP-43A315T: p = 0.030 anterograde and 0.045 retrograde;
Figure 2F; Table S1). Interestingly, we observed a significant
increase in retrograde movement of mutant TDP-43 granules as
compared to wild-type (TDP-43M337V: p = 0.037; TDP-43A315T:
p = 0.042; Figure 2H).
To determine whether TDP-43 mutations result in generalized
disruption of anterograde transport, wemonitoredmitochondrial
trafficking and TDP-43 granule trafficking simultaneously in
the same cells. In primary cortical neurons, axonal transport of
mitochondria was indistinguishable between cells expressing
WT or mutant TDP-43 (M337V or A315T mutants) at 5–7 days
in culture (Figures 2G and 2I; Table S1) despite a significant
defect in axonal transport of TDP-43 granules. We conclude
that TDP-43 mutation results in a selective defect in the traf-
ficking of TDP-43-containing granules, although this could lead
to broader cellular toxicity and a more generalized defect in
axonal transport in neurons cultured for longer periods of time
(Wang et al., 2013).
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Figure 3. Nefl mRNA Is Transported Bidi-
rectionally along Primary Cortical Neuron
Axons and Is Part of an mRNP Granule that
Contains TDP-43
(A) mRNA beacons are designed to target Nefl
mRNA. The beacon emits a fluorescence signal
once it linearizes upon hybridization with its target
mRNA. (B) Nefl mRNA fluorescence is present in
the soma and along primary cortical neuron axons.
Scale bar, 10 mm. (C) Nefl mRNA was detected in
distal axonal compartments and inside growth
cones. Scale bar, axons 10 mm; growth cone 2 mm.
(D)NeflmRNA granule (arrowheads) is transported
along the axon of a cortical neuron. Scale bar,
5 mm. (E) TDP-43 is present in the motile mRNA
granule in a cortical neuron. Scale bar, 10 mm. (F)
Granules containing TDP-43 and NeflmRNA show
predominately anterograde movements and net
anterograde displacement, whereas those that
contain Nefl without TDP-43 show predominately
retrograde movements and net retrograde
displacement.
Neuron
ALS Mutations Impair TDP-43 Granule TraffickingTDP-43 Is a Component of Trafficked mRNP Granules
and Facilitates Trafficking of Cognate mRNA
We and others have shown that TDP-43 interacts with a network
of RNA-binding proteins (Fallini et al., 2012; Freibaumet al., 2010;
Ling et al., 2010). The TDP-43 interactome includes numerous
proteins involved in RNA trafficking, suggesting that some frac-
tion of TDP-43 is a component of mRNP granules transported
alongneuronal axons. TDP-43coimmunopurifies andcolocalizes
with the RNA trafficking protein Staufen (Figures S3A and S3B).
Further, we determined that actively transported axonal TDP-43
granules stain positivelywith SYTORNASelectGreen fluorescent
stain, consistent with the notion that TDP-43 granules trans-
ported along axons of cortical neurons contain RNA (Figure S3C).
A limitation of SYTO RNASelect stain is that it is a nonspecific,
general RNA dye. To investigate the association of TDP-43 with
one of its well-characterized mRNA targets, we designed an
‘‘mRNA beacon’’ consisting of a Cy3-tagged oligonucleotide
that specifically hybridizes to mouse or human Neurofilament-L
(Nefl orNEFL, respectively) mRNA and studied mRNA traffickingNeuron 81, 536–543in live cells (Figure 3A; Figures S3D and
S3E). Neurofilament-L mRNA has a
consensus TDP-43 binding site in its
30 UTR and binds TDP-43 in extracts
from human and mouse brain tissue (Pol-
ymenidou et al., 2011; Volkening et al.,
2009). Fluorescence emission from the
mRNA beacon is quenched until hybridi-
zation to Nefl mRNA and conjugation to
a NeutrAvidin polypeptide prevents accu-
mulation of beacon in the nucleus (Fig-
ure 3A; Figure S3E). Live fluorescent
imaging of mouse cortical neurons
showed that Nefl mRNA is present
throughout the axonal compartment and
can be observed distally, even in thegrowth cones (Figures 3B and 3C). Nefl mRNP granules moved
bidirectionally along axons with intermittent rapid movements
indistinguishable from those of TDP-43 granules (Figure 3D;
Movie S2). Nefl mRNP granules existed in two fractions: those
colocalized with fluorescently labeled TDP-43 (Figure 3E) and
those without any TDP-43 staining. Importantly, these two frac-
tions showed different trafficking behavior. Specifically, Nefl
mRNP granules that contained TDP-43 showed net anterograde
movement, whereas those NeflmRNP granules without TDP-43
showed net retrograde movement (Figure 3F). We conclude
that TDP-43 is specifically associated with mRNP granules that
promote anterograde transport of certain mRNAs, is a marker
of such granules, and could even participate in this process.
Defective Trafficking of TDP-43CognatemRNA inMotor
Neurons Derived from ALS Patients with TDP-43
Mutations
The data derived from Drosophila motor neurons and mouse
cortical neurons consistently show that TDP-43 granules, February 5, 2014 ª2014 Elsevier Inc. 539
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ALS Mutations Impair TDP-43 Granule Traffickingundergo bidirectional transport and that this is selectively
impaired by ALS-causing mutations in TDP-43. These data
were generated by monitoring the trafficking of exogenous, fluo-
rescently-tagged TDP-43. While this is standard in the trafficking
field, there remains a possibility that overexpression of TDP-43
influences its behavior in these assays. The mRNA beacon that
we describe here, combined with recent advances in induced
pluripotent stem (iPS) cell technology to generate motor neurons
from ALS patients, affords a novel opportunity to corroborate
our results in a relevant human cell type with endogenous wild-
type or mutant TDP-43 expressed at physiological levels.
Thus, we analyzed NEFL transport in iPS cell-derived human
motor neurons carrying both of the ALS-causing mutations
we analyzed in Drosophila and mouse cortical neurons (M337V
and A315T) and one additional ALS-causing mutation (G298S).
The cells derived from an ALS patient with the M337V mutation
were described previously (Bilican et al., 2012). These motor
neurons exhibit increased cytoplasmic TDP-43 in the soma,
accumulation of insoluble TDP-43, and accelerated cell death
relative to control cells (Bilican et al., 2012). We monitored the
movement of NEFL mRNP granules in axons of HB9-positive
control or ALS motor neurons (TDP-43M337V; patient 31) in three
timewindows over 2 consecutive weeks after plating and prior to
the observation of cell toxicity. NEFLmRNP granules underwent
bidirectional, rapid movements that were interrupted by brief
pauses in the axons of control andALSmotor neurons (Figure 4B;
Movie S3). The cells were monitored for a period of 2 weeks,
after which it was not possible to clearly recognize individual
axonal tracks extending from the cell soma to the growth
cones without obstruction by glial cells or a significant decrease
in the fluorescent intensity of the mRNA beacon. During
the first week after plating, granule transport velocities, net
displacement, and directionality were indistinguishable between
control and ALS motor neurons. By days 9–13, a defect in the
transport of NEFL mRNP granules became apparent in ALS
motor neurons. Specifically, anterograde transport of the NEFL
mRNP granules significantly decreased (Figure 4C). The fre-
quency of reversals and the overall fraction of retrogradely
moving granules also increased significantly in the ALS motor
neurons (p = 0.011 and p = 0.028, respectively), demonstrating
less efficient transport mechanisms of NEFL mRNA (Figures
4C, 4E, and 4F).
Given the inherent variability in motor neurons differentiated
from human iPS cells, we generated additional control (Control
line 2; patient 11 [Boulting et al., 2011]) and mutant iPS cell
lines (TDP-43G298S and TDP-43A315T; patients 47 and RB20,
respectively) (Figure 4A; Figure S4). Examining these addi-
tional cell lines permitted us to determine whether impaired
TDP-43 granule trafficking is solely a consequence of the
M337V mutation or occurs more broadly with other TDP-43
mutations. In these cells, we monitored the movement of
NEFL mRNA granules in four time windows over 17 days after
plating. Our results again showed significant decrease in
anterograde displacement that was quite profound 10 days
after plating and becomes progressively worse with time (Fig-
ure 4D). We observe a significant increase in the frequency
of reversals and retrograde movement of NEFL mRNA gran-
ules in iPS cell-derived motor neurons from ALS patients as540 Neuron 81, 536–543, February 5, 2014 ª2014 Elsevier Inc.compared to wild-type after 9 days in culture (Figures 4D
and 4E).
DISCUSSION
Here we establish that TDP-43 is a component of mRNP trans-
port granules in neurons, including human stem cell-derived
motor neurons, and identify a new role for TDP-43 in the cyto-
plasm supporting anterograde axonal transport of target
mRNAs from the soma to distal axonal compartments, including
the NMJ. We also establish that three different ALS-causing
mutations of TDP-43 impair this cytoplasmic function. This
partial loss of function is consistent with the inability of mutant
TDP-43 to complement a deficiency of endogenous TBPH in
Drosophila. This transport defect is specific for TDP-43-positive
mRNP granules, since another microtubule-dependent cargo in
the same cells is transported normally during the same observa-
tion window. We conclude that deficient axonal transport of
mRNA targeted by TDP-43 may contribute to pathogenesis of
ALS and related diseases such as FTD.
Given the dominant inheritance of TDP-43 mutations in ALS,
this defect in TDP-43 trafficking is unlikely to be the sole
contribution of mutant TDP-43 to disease. Nevertheless, this
clear and consistent defect in TDP-43 granule transport is
likely an important contributor to ALS, perhaps influencing
specific disease features such as cell-type specificity or the
pattern of degeneration. ALS has been described as a ‘‘distal
axonopathy’’ because morphological abnormalities of the
distal axon, including dismantling of the NMJ leading to dener-
vation, are among the earliest pathological features (Fischer
et al., 2004). Many of the mRNA targets of TDP-43
encode proteins that function in this compartment but only a
subset show differential splicing with altered TDP-43 levels
or TDP-43 mutations (Lagier-Tourenne et al., 2012; Poly-
menidou et al., 2011). One might speculate that a failure
of TDP-43 to adequately support spatially appropriate trans-
lation of target mRNAs could contribute to this pattern of
neurodegeneration.
The mechanism whereby disease-causing mutations impair
granule transport is unclear but could involve a defect in the
ability of mutant TDP-43 granules to engage motor proteins
or a physical impediment to their movement based on some
abnormality in their size or shape. However, it is worth noting
that these disease mutations all impact a prion-like domain in
the C terminus of TDP-43. Prion-like domains in TDP-43 and
related RNA-binding proteins mediate the assembly of RNA
granules, and disease mutations in these prion-like domains
disturb the dynamics of RNA granule assembly and disas-
sembly (Ramaswami et al., 2013). Normally, RNA transport
granules in neurons are highly dynamic (Barbee et al., 2006)
and this relates to their ability to deliver mRNAs to distal sites
for local translation (Krichevsky and Kosik, 2001). The correla-
tion between the impairment of RNA granule dynamics and
impairment of RNA granule transport by ALS mutations sug-
gests the possibility of a heretofore unappreciated role for
RNA granule dynamism and transport that will require addi-
tional research to elucidate. The important take home mes-
sages from this study are that TDP-43 has a cytoplasmic
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along Human Motor Neuron Axons
(A) Human motor neurons were derived from iPS
cells, as illustrated with immunostaining for motor
neuron markers like Islet. For live imaging, we
identified cells based on expression of the HB9
responsive GFP construct. (B) Live imaging of
stem cell-derived human motor neurons shows
endogenous NEFL mRNA transport along axons.
Scale bar, 5 mm. (C) There is no significant differ-
ence in net anterograde displacement of NEFL
mRNA granules in control versus patient motor
neuronswith TDP-43M337Vmutation during the first
week of observation. The transport defect was
apparent 9 days after plating when a significant
decrease in net anterograde transport of NEFL
mRNA granules is observed. (D) NEFL mRNA
anterograde displacement was significantly
altered in human motor neurons from iPS cells of
ALS patients with TDP-43G298S mutation after
5 days in culture as compared to control. After
9 days in culture, mRNA anterograde transport is
significantly altered in motor neurons from all ALS
patients as compared to control. This defect be-
comes more pronounced over time. (E) Frequency
of NEFL mRNA granule reversals per hour is
significantly higher in neurons with mutant TDP-43
as compared to control 2 weeks after plating (p <
0.001). (F) The percentage of retrogradely moving
NEFL mRNA granules is significantly higher in
9 days in vitro neurons from ALS patients with
mutant TDP-43. All error bars are shown asmean ±
SEM.
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ALS Mutations Impair TDP-43 Granule Traffickingfunction that is impaired by disease-causing mutations;
TDP-43 is a component of neuronal RNA transport granules;
association of target mRNAs with TDP-43 correlates with
their anterograde transport; and ALS-causing mutations in
TDP-43 impair this transport in vivo in Drosophila, in mouse
cortical neurons, and in iPS-derived motor neurons from ALS
patients.EXPERIMENTAL PROCEDURES
Drosophila
Third-instar Drosophila larvae genotypes OK371 > Gal4/ UAS-Venus-TDP-43
WT, OK371 > Gal4/ UAS-Venus-TDP-43 M337V, and OK371 > Gal4/UAS-
YFP-TDP-43 A315T were used for axonal transport imaging. For TDP-43
quantification at the cell body and synaptic terminal, UAS-CD8-RFP
(BloomingtonStockCenter; stock 27391)was coexpressed, resulting in the ge-
notypes: OK371 > Gal4, UAS-CD8-RFP/ UAS-TDP-43 WT or OK371 > Gal4,
UAS-CD8-RFP/ UAS-TDP-43 M337V, OK371 > Gal4, UAS-CD8-RFP/UAS-
TDP-43 A315T, and negative control-OK371 > Gal4, UAS-CD8-RFP/+.Neuron 81, 536–543OK371-Gal4 driver was used for all Drosophila
transgene expression except for the TBPH rescue
cross where Armadillo Gal4 was used. In TBPH
viability rescue cross, transgenes (UAS-Venus-
TBPH, UAS-Venus-TDP-43, and UAS-Venus-
TDP43 M337V) were expressed by Armadillo
Gal4 in TBPH D23 homozygote mutants. Controls
in this analysis included W1118, homozygotes,
and heterozygotes for the null TBPHD23mutation.Third-instar larvae were sorted by genotype and placed in separate vials. The
percentage of larvae that became living adults was recorded and graphed.
Mouse Primary Neuron Culture and Transfection
Primary mouse cortical neuron culture and transfection were conducted as
previously described (Kaech and Banker, 2006). Details are provided in
Supplemental Experimental Procedures.
Confocal Imaging
Imaging cortical neurons was done 5–8 days after plating, and human mo-
tor neurons 2–17 days after plating. For in vivo live imaging, wandering
third-instar Drosophila larvae were dissected live in HL3 medium (Stewart
et al., 1994); pinned to Sylgard in an imaging chamber; eviscerated keeping
CNS, nerves, and muscle intact; and covered with a coverslip. Time-lapse
movies were obtained using a spinning-disc confocal Marianas system
(Intelligent Imaging Innovations) configured on a Zeiss Axio Observer.
Further details can be found in Supplemental Experimental Procedures.
Image and Movie Analysis
In live Drosophila larvae samples, images of the NMJ at muscle 13 were
examined for levels of Venus-TDP-43 fluorescence. Time-lapse movies were, February 5, 2014 ª2014 Elsevier Inc. 541
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ALS Mutations Impair TDP-43 Granule Traffickinganalyzed using SlideBook 5.5 or Imaris 7.6 (Bitplane Science Software) with
the manual particle-tracking module. Granules that moved >3 mm during the
length of the movie were analyzed. In mouse cortical neurons, when granules
changed direction, they were considered a new particle. However, in the
moving versus stationary analysis, granules changing direction were counted
as one moving particle.
Imaging Mitochondrial Transport
For live-cell imaging of mitochondria, cells transfected with fluorescent
TDP-43 (wild-type or mutant) were incubated for 20 min in imaging media
containing either Mitotracker Red FM (25 nM; Invitrogen) or Mitotracker Green
FM (20 nM; Invitrogen). The cells were then imaged using live fluorescent
confocal microscopy as described above.
Coimmunoprecipitation
FLAG-tagged expression plasmids were transfected into HEK293T cells using
Fugene 6 as recommended by manufacturer. Mock-transfected cells were
used as negative control, and a 10 cm plate was used for each coimmunopre-
cipitation. Forty-eight hours later, cells were lysed and lysates were cleared by
centrifugation at 21,000 3 g. Clarified lysates were precleared with normal
mouse IgG agarose and protein G agarose prior to coimmunoprecipitation
with anti-FLAG (M2, Sigma) agarose. Beads were washed and immmuno-
purified proteins were eluted with FLAG peptide (Sigma). Proteins were
separated by SDS-PAGE prior to protein identification by mass spectrometry.
Where indicated, 45 mg RNase A was added to each lysate prior to
coimmunoprecipitation.
Western Blotting
To study the interaction between Stau1 and TDP-43, we separated samples
by SDS-PAGE using AnyKD tris-glycine gels (Bio-Rad) and transferred them
to PVDF membrane. To detect expression levels of TDP-43, we collected,
homogenized, and reduced per lane three Drosophila third-instar larvae
brains. These samples were separated by SDS-PAGE using Novex NuPAGE
Bis-Tris (Life Technologies) gels. Anti-TDP43 (Santa Cruz, sc-100871) and
anti-STAU1 (ProteinTech, 14225-1-AP) were used.
mRNA Beacon Design, Synthesis, and Testing
Beacon loop sequences of 23–25 nt were designed manually to detect the
mouse or human NFL transcript using three different programs in parallel: (1)
OLIGOWALK, (2) mFold, and (3) MicroInspector. Using this approach,
beacons were predicted to stably hybridize to single-stranded regions of the
transcript in areas not bound by endogenous microRNAs (Bratu et al., 2003).
Beacons were synthesized using a nuclease-resistant 20-O-methylribonucleo-
tide backbone and were prevented from nuclear localization by conjugation to
NeutrAvidin (Chen et al., 2009, 2010). Beacons were synthesized with a biotin-
modified-dT nucleotide in the 30 stem sequence and were labeled with 50 Cy3
and 30 BHQ2 by Sigma Aldrich. The beacon sequences are Nefl
50-Cy3 GCTCAATCTTTCTTCTTAGCCACC(Bio-dt)gagc BHQ2-30, NEFL 50-
Cy3 cacaGGTTCAATCTTTCTTCTTAGCTGC(Bio-dT)gtg BHQ2-30. Underlined
sequences form the self-hybridizing stem sequence and uppercase letters
hybridize to the transcript. Nefl beacon hybridization to its target sequence
was tested in vitro using synthetic oligonucleotides in solution. Nefl beacon
hybridized rapidly with its target and high specific fluorescence was detected.
Further details are provided in Supplemental Experimental Procedures.
Generation and Characterization of TDP-43 iPS Cell Lines
iPS cell lines characterized in this study were TDP-43A315T and TDP-43G298S.
Dermal biopsies were obtained from two familial ALS patients with mutations
in the TARDBP locus. From these explants, fibroblasts were generated and
expanded in KO-DMEM (Life Technologies) supplemented with 10% FBS
(Hyclone). TDP-43 iPS cells were derived by transduction of fibroblasts with
retroviruses expressing OCT4, SOX2, and KLF4. After 3–4 weeks, primary
iPS cell colonies were picked based on morphology and independently
expanded in mTeSR 1 medium (STEMCELL Technologies) to generate four
to six different iPS cell lines/patient. The presence of the mutations was
confirmed by PCR amplification of a genomic region surrounding Exon 6,
followed by Sanger DNA sequencing. The pluripotency of the iPS cell lines542 Neuron 81, 536–543, February 5, 2014 ª2014 Elsevier Inc.used was validated using the TaqMan hPSC Scorecard Panel (Life Technolo-
gies). Expression of transcription factors and cell surface antigens character-
istic of the pluripotent state was confirmed using immunocytochemistry.
Primary antibodies and dilution factors used for this purpose were NANOG
(1:100, R&D), OCT3/4 (1:500, Santa Cruz), SSEA-4 (1:1,000, Santa Cruz),
and TRA-1-81 (1:1,000, Millipore).
iPS and Derived iPS Motor Neurons
Detailed description can be found in the Supplemental Experimental
Procedures section. Briefly, iPS cells were maintained on a monolayer of
neomycin-selected mouse embryonic fibroblasts (MEFs; Millipore) in hiPS
media (Bilican et al., 2012; Dimos et al., 2008). To generate motor neurons,
we incubated undifferentiated iPS cells with 10 mM Y27632 (Calbiochem),
then passaged, triturated, and placed them into ultra-low adherent culture
dishes (Corning) for seeding of embryoid bodies (EBs). For the first
11 days, cells were kept in suspension in hiPS media without bFGF. At
day 11, EBs were switched to neural induction medium. At day 28, EBs
were dissociated, transfected using Lonza Nucleofector with mRNA beacons
and HB9 (9Kb)-promoter-GFP, and plated onto PDL/laminin-coated (BD Bio-
sciences) glass (Kaech and Banker, 2006). To prepare the cells for live imag-
ing, we allowed cells to settle on glass coverslips flipped over primary glial
monolayers.
Statistical Analyses
Statistical analyses were performed with Prism6 (GraphPad Software).
Comparing the TDP-43 wild-type to mutant TDP-43 data sets yielded all
p values. A Mann-Whitney unpaired test with one-tailed p value was
completed for comparing distances traveled, velocity analysis, and the direc-
tional percentages of granules within populations. A one-way ANOVA test
followed by a Tukey test was completed for the TBPH rescue analysis.
KaleidaGraph (Synergy Software) was used to make the axonal particle
trafficking distance and velocity bar graphs. All error bars are shown as
mean ± SEM.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, one table, and three movies and can be found with this article
online at http://dx.doi.org/10.1016/j.neuron.2013.12.018.
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